Double Blind, Placebo Controlled Phase 3 Study of the Efficacy of an Investigational Vero Cell-Derived Influenza Vaccine (VCIV) to Prevent Culture Confirmed Influenza Infection (CCII).
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2009
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics; Therapeutic Use
- 12 Aug 2009 Actual patient number (3670) added as reported by ClinicalTrials.gov.
- 01 Dec 2008 Dec 2008 added as the actual completion date, based on information from ClinicalTrials.gov.
- 01 Dec 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.